The Government of the United States of America as Represented by the Secretary of the Department of;GlaxoSmithKline Biologicals SA
发明人:
Nancy J. Sullivan,Gary J. Nabel,Clement Asiedu,Cheng Cheng,Alfredo Nicosia,Riccardo Cortese,Virginia Ammendola,Stefano Colloca
申请号：
US16751470
公开号：
US20200149069A1
申请日:
2020.01.24
申请国别(地区):
US
年份:
2020
代理人:
摘要：
This invention provides vaccines for inducing an immune response and protection against filovirus infection for use as a preventative vaccine in humans. In particular, the invention provides chimpanzee adenoviral vectors expressing filovirus proteins from different strains of Ebolavirus (EBOV) or Marburg virus (MARV).
